Supplemental Table 4.
Associations between gestational diabetes mellitus, preexisting diabetes mellitus, and body mass index and COVID-19 diagnosis in the INTERCOVID study with a real-time polymerase chain reaction or an antigen test at any time in the pregnancy (n=1290)
| Variable | N (%) | Crude RR (95% CI) | Adjusted RR (95% CI) |
|---|---|---|---|
| Model 1 | |||
| GDM or DM | |||
| No GDM, no DM | 1123 (87.1) | Ref | Ref |
| GDM, no DM | 123 (9.5) | 1.13 (0.95–1.35) | 1.18 (0.99–1.40)a |
| Preexisting DM | 44 (3.4) | 1.52 (1.27–1.83)b | 1.60 (1.33–1.91)b |
| BMI | |||
| Normal weight (<25 kg/m2) | 750 (58.1) | Ref | Ref |
| Overweight or obese (≥25 kg/m2) | 540 (41.9) | 1.27 (1.13–1.43)b | 1.24 (1.11–1.40)b |
| Model 2 | |||
| No GDM or DM, normal weight | 696 (54.0) | Ref | Ref |
| No GDM or DM, overweight or obese | 427 (33.1) | 1.26 (1.11–1.43)b | 1.23 (1.09–1.40)b |
| GDM without insulin, normal weight | 34 (2.6) | 0.93 (0.60–1.44) | 0.96 (0.63–1.45) |
| GDM without insulin, overweight or obese | 58 (4.5) | 1.30 (1.01–1.68)b | 1.33 (1.04–1.72)b |
| GDM with insulin, normal weight | 9 (0.7) | 1.62 (1.01–2.60)b | 1.73 (1.13–2.64)b |
| GDM with insulin, overweight or obese | 22 (1.7) | 1.88 (1.47–2.40)b | 1.91 (1.52–2.41)b |
| Preexisting DM, normal weight | 11 (0.9) | 1.55 (0.98–2.44)a | 1.63 (1.05–2.53)b |
| Preexisting DM, overweight or obese | 33 (2.6) | 1.92 (1.57–2.34)b | 1.97 (1.62–2.38)b |
Data were adjusted for maternal age, parity, and tobacco use during pregnancy.
CI, confidence interval; BMI, body mass index; DM, diabetes mellitus; GDM, gestational diabetes mellitus, RR, risk ratio.
Eskenazi et al. COVID-19 and gestational diabetes, diabetes, and body mass index in pregnant women. Am J Obstet Gynecol 2022.
a
P<.1
b
P<.05.